ストックスクリーナーアプリを入手
2.92
7.59%
-0.24
プレマーケット:
2.87
-0.05
-1.71%
前日終値:
$3.16
開ける：
$3.17
24時間の取引高:
6.78M
Relative Volume:
1.24
時価総額：
$651.95M
収益：
-
当期純損益:
$-283.26M
株価収益率:
-1.9864
EPS:
-1.47
ネットキャッシュフロー:
$-273.61M
1週間 パフォーマンス:
-19.56%
1か月 パフォーマンス:
+76.97%
6か月 パフォーマンス:
-49.66%
1年 パフォーマンス:
-42.29%
1日の値動き範囲:
$2.90
$3.275
1週間の範囲:
$2.90
$3.86
52週間の値動き範囲:
$1.52
$12.00
Sana Biotechnology Inc Stock (SANA) Company Profile
名前
Sana Biotechnology Inc
セクター
電話
(206) 701-7914
住所
188 EAST BLAINE STREET, SUITE 400, SEATTLE
SANA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SANA
Sana Biotechnology Inc
|
2.92 | 651.95M | 0 | -283.26M | -273.61M | -1.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Sana Biotechnology Inc Stock (SANA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-01-08 | アップグレード | TD Cowen | Hold → Buy |
| 2024-11-05 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-06-26 | 開始されました | Rodman & Renshaw | Buy |
| 2024-01-16 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2023-09-25 | 開始されました | JMP Securities | Mkt Outperform |
| 2023-09-05 | 開始されました | Citigroup | Buy |
| 2023-08-14 | 開始されました | TD Cowen | Market Perform |
| 2023-05-02 | 開始されました | H.C. Wainwright | Neutral |
| 2021-03-01 | 開始されました | BofA Securities | Buy |
| 2021-03-01 | 開始されました | Goldman | Neutral |
| 2021-03-01 | 開始されました | JP Morgan | Neutral |
| 2021-03-01 | 開始されました | Morgan Stanley | Overweight |
すべてを表示
Sana Biotechnology Inc (SANA) 最新ニュース
There May Still Be Time to Get in on These 3 Trending Biotechs - MarketBeat
Sana Biotechnology Inc (SANA-Q) QuotePress Release - The Globe and Mail
Sana Biotechnology (NASDAQ:SANA) Shares Gap DownShould You Sell? - MarketBeat
Sana Biotechnology (NASDAQ:SANA) Trading Down 5.5%Here's Why - MarketBeat
Layoff Tracker: Notch Therapeutics to ‘Significantly Reduce’ Workforce - BioSpace
As researchers push for a type 1 diabetes cure, Sana Biotechnology provides a nudge forward - STAT
Sana Biotechnology (NASDAQ:SANA) Shares Down 5.5%Here's What Happened - MarketBeat
Sana Biotechnology (NASDAQ:SANA) Stock Price Up 5.7%Here's Why - MarketBeat
Sana Biotechnology price target raised to $12 from $9 at Morgan Stanley - MSN
SANA Stock Surges 152% in a Week on Upbeat Initial Diabetes Study Data - MSN
Sana Biotechnology (NASDAQ:SANA) Shares Up 5.7%Time to Buy? - MarketBeat
This Biotech Penny Stock Is Up 120% This Year. Analysts Think It Can Still Triple From Here in 2025. - MSN
Sana Biotechnology Shows Promise with Hypoimmune Platform - TipRanks
Sana Biotechnology, Inc. (NASDAQ:SANA) Shares Purchased by Barclays PLC - MarketBeat
FMR LLC sells $1.89 million in Sana Biotechnology shares By Investing.com - Investing.com South Africa
SANA Stock Surges 152% In A Week On Upbeat Initial Diabetes Study Data - Barchart
FMR LLC Reduces Holdings in Sana Biotechnology Inc - GuruFocus.com
Insider Selling: Sana Biotechnology, Inc. (NASDAQ:SANA) Insider Sells 290,912 Shares of Stock - MarketBeat
FMR LLC sells $1.89 million in Sana Biotechnology shares - Investing.com India
Sana Biotechnology (NASDAQ:SANA) Shares Gap UpHere's What Happened - MarketBeat
Top 2 Health Care Stocks That Are Ticking Portfolio Bombs - Benzinga
Sana Biotechnology could offer relief to diabetes type 1 sufferers in the future - Mugglehead
Sana Biotech extends rally as Morgan Stanley cites platform's potential - MSN
Shares of Sana soar following breakthrough in diabetes therapy trials - Kursiv Media
Sana Biotech Stock Triples After Type 1 Diabetes Trial Wows Analysts: Retail Erupts In Excitement - NewsBreak
Cowen Pounds the Table on Sana Biotechnology Stock - TipRanks
This Biotech Stock Just Soared 240%. Why It Can Go Higher. - MSN
First data for immune-evading type 1 diabetes therapy trigger Sana stock surge - FirstWord Pharma
Biotech Breakthroughs: Sana Biotechnology (NASDAQ: SANA) Type - openPR
Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance - BioWorld Online
Sana Biotechnology to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
TD Cowen Upgrades Sana Biotechnology (SANA) - MSN
Sana Biotech stock jumps on cell therapy data (SANA:NASDAQ) - Seeking Alpha
Buy reiterated for Sana stock after Phase 1 data supports unique HIP cell platform - Investing.com Canada
Crude Oil Down 1%; US Weekly Jobless Claims Decline - Benzinga
Tenvie raises $200M for brain drug R&D; Sana spikes on single patient’s results - BioPharma Dive
Sana Biotechnology skyrockets 200% on positive diabetes study data - Proactive Investors USA
Sana’s stock soars on new cell therapy data; UniQure’s $75M offering - Endpoints News
TD Cowen lifts Sana Biotech stock rating on positive IST data - Investing.com Canada
This Biotech Stock Soared 300% Overnight. Why It Can Go Higher. - MSN
Sana Biotechnology (SANA), eBay (EBAY) Are Among Today’s Big Winners - Insider Monkey
Sana’s cell therapy may be ‘transformative cure’ for type 1 diabetes: analysts - Fierce Biotech
Sana Biotechnology: Stock Price Rise Deserved Post Diabetes Cell Therapy Success - Seeking Alpha
Sana Biotechnology (NASDAQ:SANA) Sees Strong Trading Volume After Analyst Upgrade - MarketBeat
Sana Biotechnology Inc (SANA) 財務データ
収益
当期純利益
現金流量
EPS
Sana Biotechnology Inc (SANA) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| FMR LLC | See Remark 1 |
Jan 08 '25 |
Sale |
6.49 |
290,912 |
1,887,320 |
4,541,511 |
| Wyrick Susan D. | See Remarks |
Jan 02 '25 |
Option Exercise |
0.00 |
5,000 |
0 |
155,512 |
4.81%
大文字化:
|
ボリューム (24 時間):